SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery

Award Information

Agency: National Science Foundation	Branch: N/A	Award ID: 63394	Program Year/Program: 2004 / SBIR
Agency Tracking Number: 0320087	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: Articular Engineering, LLC
1818 Skokie Blvd. Suite 158 Northbrook, IL 60062
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 2004

Title: SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery

Agency: NSF

Contract: 0422194

Award Amount: $499,914.00

Abstract:
This Small Business Innovation Research Phase II project is to develop scale-up production technology to produce engineered cartilage for drug discovery using a proprietary Alginate Recovered Chondrocyte (ARC) method. This method stimulates adult human cartilage cells to form a cartilaginous tissue with proper compositional and functional properties. ARC cartilage tissue is expected to offer a cost-effective alternative to current culture systems and expensive animal studies while utilizing human tissue. The commercial application of this project will be in the area of drug discovery for cartilage-related problems such as rheumatoid arthritis.

Principal Investigator:
Brian Pfister
PI
8474989634
kmasuda@articular.com

Business Contact:
Brian Pfister
8474989634
bpfister@articular.com

Small Business Information at Submission:

Articular Engineering, LLC
1818 Skokie Blvd. Suite 158 Northbrook, IL 60062

EIN/Tax ID:

DUNS: N/A

Number of Employees:

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No